ISPON President Calls for Collaboration to Improve Safety

The International Society of Pharmacovigilance and Pharmacoepidemiology (ISPON) President — Dr. Michele M. Miller (2024‑present) — issued a public call for collaboration among regulatory agencies, pharmaceutical companies, healthcare providers, and patient groups to strengthen drug‑safety monitoring worldwide. He emphasized sharing real‑time adverse‑event data, harmonizing reporting standards, and expanding training programs to detect safety signals earlier and reduce medication‑related harm. The appeal was made in a press release and at the 2024 ISPON Annual Meeting, urging joint initiatives and resource pooling to improve pharmacovigilance infrastructure globally. Views Nigeria